Windlas Biotech Limited
Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid pharmaceutical dosage forms and provides a comprehensive range of CDMO services ranging from product discovery, product development, and commercial manufacturing of generic products, including complex generics.
What Windlas files
- Investor Meet58
- Others37
- Updates17
- Board Meeting10
- PPTs8
- Important6
Windlas Biotech has set July 16, 2026, as the Record Date. This is for shareholders to be eligible for the proposed dividend of Rs. 6.30 per equity share (126% on Rs. 5/- face value) for FY 2025-26. This dividend requires shareholder approval at the Annual General Meeting on July 23,...
Windlas Biotech has successfully completed its share buyback via a tender offer, repurchasing and extinguishing 4,70,000 equity shares at INR 1,000 per share, totaling **47.00 Cr**. The extinguishment was completed on May 18. This buyback reduced the total outstanding shares from 2.11 Cr to 2.06 Cr. Post-buyback, the promoter shareholding...
Windlas Biotech has announced a share buyback via a tender offer for up to 4.70 lakh shares at ₹1,000 per share. The total buyback size is ₹47 Cr. Tendering for the buyback opens on April 30, 2026, and closes on May 07, 2026 (excluding May 01, 2026 due to a...
Windlas Biotech's Board has approved a buyback of up to 4,70,000 equity shares, representing 2.23% of its total equity, for INR 47 Cr. The shares will be bought back at INR 1,000 each via a tender offer, with promoters not participating. Friday, April 24, 2026, is the record date to...
Windlas Biotech has announced a board meeting on July 28, 2025, for the 24th Annual General Meeting. The Record Date is set for July 21, 2025, to identify shareholders eligible for a proposed dividend of Rs. 5.80 per equity share (116% on Rs. 5 face value) for FY 2024-25, subject...